DSC Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-99,000
| Closed | -$8.65M | – | 26 |
|
|
2024
Q1 | $8.65M | Sell |
99,000
-1,000
| -1% | -$87.3K | 13.81% | 3 |
|
|
2023
Q4 | $9.64M | Hold |
100,000
| – | – | 15.93% | 3 |
|
|
2023
Q3 | $8.85M | Hold |
100,000
| – | – | 11.36% | 3 |
|
|
2023
Q2 | $8.67M | Buy |
100,000
+7,500
| +8% | +$650K | 13% | 4 |
|
|
2023
Q1 | $8.99M | Buy |
92,500
+10,000
| +12% | +$972K | 7.85% | 3 |
|
|
2022
Q4 | $8.54M | Hold |
82,500
| – | – | 19.62% | 3 |
|
|
2022
Q3 | $6.99M | Hold |
82,500
| – | – | 7.21% | 3 |
|
|
2022
Q2 | $6.84M | Buy |
82,500
+2,500
| +3% | +$207K | 6.83% | 3 |
|
|
2022
Q1 | $6.17M | Buy |
80,000
+10,000
| +14% | +$771K | 2.12% | 4 |
|
|
2021
Q4 | $6.19M | Buy |
+70,000
| New | +$6.19M | 4.78% | 4 |
|